[
    {
        "primary_name": "Upadacitinib",
        "candidates": [
            "Upadacitinib",
            "ABP-501",
            "Janus kinase 1 inhibitor",
            "JAK1 inhibitor"
        ],
        "entity_name": "Upadacitinib",
        "type": "Drug",
        "description": "A Janus kinase (JAK) 1 inhibitor used for the treatment of inflammatory bowel disease (IBD).",
        "is_ambiguous": false
    },
    {
        "primary_name": "Risankizumab",
        "candidates": [
            "Risankizumab",
            "ABBV-181",
            "IL-23 inhibitor",
            "Interleukin-23 inhibitor"
        ],
        "entity_name": "Risankizumab",
        "type": "Drug",
        "description": "An IL-23 inhibitor used for the treatment of inflammatory bowel disease (IBD).",
        "is_ambiguous": false
    },
    {
        "primary_name": "Inflammatory Bowel Disease",
        "candidates": [
            "Inflammatory Bowel Disease",
            "IBD",
            "Inflammatory bowel diseases",
            "Crohn's disease",
            "Ulcerative colitis"
        ],
        "entity_name": "Inflammatory Bowel Disease",
        "type": "Disease",
        "description": "A group of inflammatory conditions of the colon and small intestine, including Crohn's disease and ulcerative colitis.",
        "is_ambiguous": false
    },
    {
        "primary_name": "Crohn's Disease",
        "candidates": [
            "Crohn's Disease",
            "Crohn disease",
            "Crohn's",
            "Inflammatory bowel disease"
        ],
        "entity_name": "Crohn's Disease",
        "type": "Disease",
        "description": "A type of inflammatory bowel disease that causes inflammation of the digestive tract.",
        "is_ambiguous": false
    }
]